Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Zinc  COVID-19 treatment studies for Zinc  C19 studies: Zinc  Zinc   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 88% Improvement Relative Risk Ventilation 26% ICU admission 3% Respiratory failure 73% Hospitalization time 29% c19early.org/z Ibrahim Alhajjaji et al. Zinc LATE TREATMENT Is late treatment with zinc beneficial for COVID-19? Retrospective 101 patients in Saudi Arabia (March 2020 - December 2021) Lower progression (p=0.0042) and shorter hospitalization (p=0.017) Ibrahim Alhajjaji et al., Saudi Pharmaceutical J., doi:10.1016/j.jsps.2023.02.011 Favors zinc Favors control
Effect of zinc supplementation on symptom reduction and length of hospital stay among pediatric patients with Coronavirus Disease 2019 (COVID-19)
Ibrahim Alhajjaji et al., Saudi Pharmaceutical Journal, doi:10.1016/j.jsps.2023.02.011
Ibrahim Alhajjaji et al., Effect of zinc supplementation on symptom reduction and length of hospital stay among pediatric patients with.., Saudi Pharmaceutical Journal, doi:10.1016/j.jsps.2023.02.011
Mar 2023   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 101 hospitalized pediatric patients in Saudi Arabia, showing zinc treatment associated with lower respiratory failure and shorter hospitalization in unadjusted results. Patients receiving zinc were older. Authors note elevated serum creatinine and the possibility of kidney injury. This study is excluded in the after exclusion results of meta analysis: excessive unadjusted differences between groups.
risk of death, 87.6% lower, RR 0.12, p = 0.13, treatment 0 of 44 (0.0%), control 4 of 57 (7.0%), NNT 14, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm).
risk of mechanical ventilation, 26.0% lower, RR 0.74, p = 0.75, treatment 4 of 44 (9.1%), control 7 of 57 (12.3%), NNT 31.
risk of ICU admission, 2.8% lower, RR 0.97, p = 1.00, treatment 9 of 44 (20.5%), control 12 of 57 (21.1%), NNT 167.
respiratory failure, 72.7% lower, RR 0.27, p = 0.004, treatment 4 of 44 (9.1%), control 19 of 57 (33.3%), NNT 4.1.
hospitalization time, 28.6% lower, relative time 0.71, p = 0.02, treatment 44, control 57.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ibrahim Alhajjaji et al., 4 Mar 2023, retrospective, Saudi Arabia, peer-reviewed, 8 authors, study period 1 March, 2020 - 31 December, 2021.
Contact: ghufran.alhajjaji@gmail.com, nealotaibi@uqu.edu.sa, ph.nada.abutaleb@gmail.com, mmiteb@psmmc.med.sa, ph.alhajjaji@gmail.com, assalotaibi@uqu.edu.sa, bmalshehail@iau.edu.sa, me.alotaibi@psmmc.med.sa.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperZincAll
Abstract: Journal Pre-proofs Original article Effect of zinc supplementation on symptom reduction and length of hospital stay among pediatric patients with Coronavirus Disease 2019 (COVID-19) Ghufran Ibrahim Alhajjaji, Nouf Alotaibi, Nada Abutaleb, Mishal M. Alotaibi, Abdulrahman Alhajjaji, Abdulmalik S. Alotaibi, Bashayer Alshehail, Moawad E. Alotaibi PII: DOI: Reference: S1319-0164(23)00041-5 https://doi.org/10.1016/j.jsps.2023.02.011 SPJ 1587 To appear in: Saudi Pharmaceutical Journal Received Date: Revised Date: Accepted Date: 4 December 2022 18 January 2023 26 February 2023 Please cite this article as: Ibrahim Alhajjaji, G., Alotaibi, N., Abutaleb, N., Alotaibi, M.M., Alhajjaji, A., Alotaibi, A.S., Alshehail, B., Alotaibi, M.E., Effect of zinc supplementation on symptom reduction and length of hospital stay among pediatric patients with Coronavirus Disease 2019 (COVID-19), Saudi Pharmaceutical Journal (2023), doi: https://doi.org/10.1016/j.jsps.2023.02.011 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. Effect of zinc supplementation on symptom reduction and length of hospital stay among pediatric patients with Coronavirus Disease 2019 (COVID-19) Ghufran Ibrahim Alhajjaji 1, Nouf Alotaibi*2 Nada Abutaleb, Mishal M. Alotaibi3, Abdulrahman Alhajjaji4 Abdulmalik S. Alotaibi2, Bashayer Alshehail5, Moawad E. Alotaibi3 1. Ghufran Ibrahim, Pharm.D, Department of Pharmaceutical Care, Maternity and Children Hospital, Makkah, Saudi Arabia. Email: Ghufran.alhajjaji@gmail.com 2. * Nouf Alotaibi, (Corresponding author), Pharm.D, Umm Al-Qura university, Clinical pharmacy department, college of pharmacy, Makkah, Saudi Arabia. ORCID: https://orcid.org/0000-0001-7029-3089 email: Nealotaibi@uqu.edu.sa mobile: 00966533694235 1. Nada Abutaleb, Pharm.D, Department of Pharmaceutical Care, Maternity and Children Hospital, Makkah, Saudi Arabia. Email: Ph.nada.abutaleb@gmail.com 3. Mishal M. Alotaibi; MD, Family Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Email: mmiteb@psmmc.med.sa 4. Abdulrahman Alhajjaji, Pharm.D, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. Email: Ph.alhajjaji@gmail.com 2. Abdulmalik Alotaibi, Pharm.D, Umm Al-Qura university, Clinical pharmacy department, college of pharmacy, Makkah, Saudi Arabia. Email: assalotaibi@uqu.edu.sa 5. Bashayer Alshehail, Pharm.D, Pharmacy Practice Department, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia, email: bmalshehail@iau.edu.sa 3. Moawad Alotaibi; MD, Family Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Email: me.alotaibi@psmmc.med.sa Effect of zinc supplementation on symptom reduction and length of hospital stay among pediatric patients with Coronavirus Disease 2019 (COVID-19) Abstract Objectives: Zinc is considered an essential multipurpose trace element because of its ability..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit